記住我
CLINICAL COMMUNICATION
Year : 2021 | Volume
: 65
| Issue : 7 | Page : 548-553
The aftermath of COVID-19 pandemic: Rhino-orbital mucormycosis
Suhas Ashok Hooli1, Vaijayanti Nitin Gadre1, Sunita Bage2, Manoj Dnyanba Gilvarkar1
1 Department of Anaesthesiology, Grant GMC, Mumbai, Maharashtra, India
2 Department of Ear Nose Throat, Grant GMC, Mumbai, Maharashtra, India
Correspondence Address:
Vaijayanti Nitin Gadre
C/O Shri. Nitin R. Gadre, 'Suniti”- 11, General Jagannath Bhosale Marg, Near Sachivalaya Gymkhana, Oppo- Mantralaya, Mumbai - 21, Maharashtra
India
Source of Support: None, Conflict of Interest: None
CheckDOI: 10.4103/ija.ija_371_21
Introduction 
Coronavirus disease (COVID)-19 causes over-activation of the innate immune response leading to multi-organ damage. In addition to affecting the major systems like respiratory, cardiovascular and gastrointestinal tract (GIT), it targets retinal vessels also causing pyogranulomatous uveitis, choroiditis and macular micro-vascular impairment.[1] It also remains dormant in paranasal sinuses for months after acute phase infection is cured and precipitates rhino-orbital mucormycosis.
Fungal rhino-sinusitis is an ascending infection with serious life and vision-threatening consequences. We are reporting 10 such cases that were operated for functional endoscopic sinus surgery (FESS) within a period of less than 3 months after COVID-19 infection. This brief clinical overview is about the increasing cases of mucormycosis and the related anaesthesia concerns in convalescent COVID-19 patients.
These cases have highlighted the challenges before the anaesthesiologists which also emphasises the need to study the management of pandemics so that the medical fraternity would be able to manage pandemics in an efficient manner.[2]
Case History The patients reported are adults (age-group 35-75 years) either known or newly diagnosed diabetics; they had history of hypertension and ischaemic heart disease (IHD) and had recently recovered from COVID-19 infection. The presenting complaints for rhinootolaryngology consultation were headache, swelling and pain in either eye and pain over face on the same side. They were receiving all medications as per physician advice. Oral hypoglycaemics were discontinued and patients were shifted to insulin regimens with strict blood glucose monitoring pre-operatively. Anti-hypertensives, statins and anti-inflammatory agents were continued. Anti- fungal regimen, either conventional or lipophilic amphotericin B was continued with monitoring of renal functions.
Pre-anaesthetic airway evaluation was done after taking due COVID-19 precautions. All routine investigations were done [Table 1]. Patients were ambulatory; six-minute walk test results were provided by chest physician. Most of the cases had anticipated difficulty in intubation due to compromised oral and dental hygiene, fungal discoloration and occasional bleeding on touch of throat and palate. Mask holding was also difficult due to pain and proptosis. Positioning for airway ease was restricted due to pain and stiffness in diabetics. Pre-operative preparation included pre- and intra-operative optimisation of blood sugar, control of hydration status due to post- COVID-19 poor general condition and inability to drink and swallow freely due to painful and/or obstructing fungal lesions and anticipated hypotension due to ongoing anti-fungal therapy.
After ensuring use of adequate personal protective equipment (PPE) including N95 masks, face shields and availability of aerosol control measures, appropriate risk consent and temperature were checked and intravenous line was accessed. Electrocardiography (ECG), pulse oximetry, non-invasive blood pressure (NIBP) monitors were connected. A difficult intubation cart was kept ready. Patients were pre-medicated with injection glycopyrrolate 4 μg/kg, injection fentanyl 2 μg/kg, intravenously. After pre-oxygenation with 100% oxygen, they were induced with injection propofol 2 mg/kg in titrated doses. The palatal perforation if present (Case no. 10) was covered with gauze and intubation performed with proper size cuffed reinforced endotracheal tube after relaxation with injection succinylcholine 1.5 mg/kg. Injection xylocard (Lignocaine Hydrochloride 2%) 1.5 mg/kg was used to attenuate laryngoscopy response. In cases of difficulty, C-MAC video laryngoscope (KARL STORZ) was used to accomplish safe intubation.
Intra-operative blood sugar monitoring was done. The patients were maintained on oxygen, nitrous oxide (50:50) and isoflurane 1% or sevoflurane with controlled ventilation. Muscle relaxation was maintained with injection atracurium 0.5 mg/kg. Intra-operative endoscopic views of the fungal infection were obtained [Figure 1]. On completion of surgery, neuromuscular blockade was reversed and after ascertaining adequate muscle power, patients were extubated and shifted to recovery with oxygen 2 L/min via Hudson-mask. The rest of the post-operative period was monitored either in the ward with analgesic cover of 15 mg/kg IV paracetamol or in the intensive care unit (ICU) on elective ventilation depending upon the clinical condition [Table 1].
Discussion Occurrence of sinusitis, either allergic, non-allergic or infective, is commonly reported in the general population. Up to 90% cases are of fungal aetiology.[3] In the year 2021, we noticed a steep rise (almost four times) in number of FESS cases in our institution for removal of mucormycosis, when compared to the last two years.
Chakraborty et al. have reported that the rational approach towards prognosis and treatment of fungal sinusitis is not yet standardised and therefore the incidence is high. They proposed the classification of fungal sinusitis as invasive and non-invasive.[4]
Fungal rhinosinusitis is often an ascending infection affecting the orbit via vascular invasion of fungal hyphae of mucorales. It is an opportunistic infection found in immunocompromised patients.[5]
Patients with invasive fungal infections have Cryptococci or Pneumocystis infections. The use of antifungal agents is said to change the epidemiology of Candida albicans to non-albican Candida strains The explanation for high mortality rates of such patients are due to resistance to antifungal agents, underlying serious medical diseases, seropositive status and inability to achieve early source control.[6] Castelnuovo et al.[7] studied fungal sinusitis cases (1050 patients) over a period of three years and found Aspergillus fumigatus (76.9% cases) to be the most often occurring mycetes. They reported patients presenting with facial pain followed by nasal obstruction with computed tomography (CT) showing focal areas of non-homogeneous intensity and metal like endo-sinus calcifications in 84.4% cases.
The acute pulmonary injury in COVID-19 is due to release of pro-inflammatory cytokines like interleukin (IL-1, 2, and 6) and tumour necrosis factor (TNF)-alpha. National Health Commission of China has included tocilizumab, a novel monoclonal antibody that competitively inhibits binding of IL-6 to its receptor in COVID -19 treatment and our protocol also includes the same. Tocilizumab binds soluble as well as bound IL-6 receptors and hinders pro-inflammatory effects of the virus.[8] Our reported cases were post- COVID and had received steroids and/or tocilizumab treatment as per department protocol.
FESS has been reported to be curative for fungal ball. In cases of fulminant invasive mycoses, surgery prevents endo-cranial complications.
High doses of systemic amphotericin B are given to control underlying disease; it is given as an infusion over 2-6 hours to reduce the severity and frequency of side effects of rapid administration. Amphotericin B is the primary antifungal therapy for patients with opportunistic fungal infections although antifungals have poor penetration ability at the site of infection.[9] Our patients received it in a dose of 1 mg/kg body weight titrated over 3 days. Hypokalaemia, hypomagnesemia, fever, chills, dyspnoea, and hypotension are common side effects of Amphotericin B. Allergic reactions, seizures, anaemia, and thrombocytopenia are less likely to occur but are well-documented. Renal function is also impaired, and a permanent decrease in the glomerular filtration rate is likely.
Our patients frequently had difficult airway, intraoperative hypotension with occasional arrhythmias that responded to treatment with lidocaine. We were careful about renal, electrolyte, coagulopathy, haemodynamic, and respiratory aberrancies during the anaesthetic management of these patients because of the risk associated with all major systemic functions.[10]
Conclusion Rhino-orbital mucormycosis is a serious aftermath of COVID-19, An effective multi-disciplinary approach can help to tackle this deadly disease.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form, the legal guardian has given his consent for images and other clinical information to be reported in the journal. The guardian understands that names and initials will not be published and due efforts will be made to conceal identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
References 
留言 (0)